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Abstract
Objectives: The optimal strategy for the reconstruction of the pancreas following pancreaticoduo-
denectomy (PD) is still debated. The aim of this study was to compare the outcomes of isolated Roux loop
pancreaticojejunostomy (IRPJ) with those of pancreaticogastrostomy (PG) after PD.
Methods: Consecutive patients submitted to PD were randomized to either method of reconstruction.
The primary outcome measure was the rate of postoperative pancreatic fistula (POPF). Secondary
outcomes included operative time, day to resumption of oral feeding, postoperative morbidity and
mortality, and exocrine and endocrine pancreatic functions.
Results: Ninety patients treated by PD were included in the study. The median total operative time was
significantly longer in the IRPJ group (320 min versus 300 min; P = 0.047). Postoperative pancreatic fistula
developed in nine of 45 patients in the IRPJ group and 10 of 45 patients in the PG group (P = 0.796). Seven
IRPJ patients and four PG patients had POPF of type B or C (P = 0.710). Time to resumption of oral
feeding was shorter in the IRPJ group (P = 0.03). Steatorrhea at 1 year was reported in nine of 42 IRPJ
patients and 18 of 41 PG patients (P = 0.029). Albumin levels at 1 year were 3.6 g/dl in the IRPJ group and
3.3 g/dl in the PG group (P = 0.001).
Conclusions: Isolated Roux loop PJ was not associated with a lower rate of POPF, but was associated
with a decrease in the incidence of postoperative steatorrhea. The technique allowed for early oral feeding
and the maintenance of oral feeding even if POPF developed.
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Introduction
Although operative mortality in patients undergoing
pancreaticoduodenectomy (PD) has fallen to <5%, incidences
of postoperative morbidity remain high at 40–50%.1–4 The
occurrence of postoperative pancreatic fistula (POPF) remains
challenging, even at high-volume centres, and contributes signifi-
cantly to increases in hospital stay, costs and mortality. Intra-
abdominal collection, delayed gastric emptying, postoperative
haemorrhage and sepsis are common sequelae of pancreatic
leakage.3–5 Incidences of POPF after PD range from 5% to 30%.3–7
Many technical modifications of the pancreatic anastomosis
have been proposed and evaluated in attempts to prevent POPF.
The best type of pancreatic reconstruction and anastomotic tech-
nique are still debated.2,4–6 The two most common methods of
pancreatic anastomosis are pancreaticojejunostomy (PJ) and
pancreaticogastrostomy (PG). Comparisons of the short-term
outcomes of these two methods of reconstruction show mixed
results.2–5,8–10 Longterm outcomes, including morphological out-
comes and exocrine and endocrine functions of the remaining
pancreas, have yet to be determined.9,11–13
The concept of isolated Roux loop PJ (IRPJ) is based on the
theory that reducing the activation of pancreatic juice by biliary
secretion will decrease the incidence and severity of POPF.14–17ClinicalTrials.gov ID: NCT01859806.
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Recent prospective randomized studies have compared the out-
comes of IRPJ with those of conventional PJ,14–17 but not with
those of PG.
Hence, the purpose of this study was to compare the outcomes
of IRPJ with those of PG after PD with regard to the rate of
occurrence of POPF, postoperative morbidity and mortality, and
exocrine and endocrine pancreatic functions in a prospective
randomized study.
Materials and methods
Patients
Consecutive patients undergoing PD for periampullary tumours
at the Gastroenterology Surgical Centre, Mansoura, Egypt, during
the period from January 2011 to May 2013 were eligible for the
study. Exclusion criteria denied the inclusion of patients with
locally advanced periampullary tumours or metastases, patients
undergoing bilioenteric or gastroenteric bypass or total pancrea-
tectomy, and patients with advanced liver cirrhosis (Child–Pugh
class B or C) with portal hypertension, malnutrition or
coagulopathy.
Informed consent was obtained from all patients included in
the study after the nature of the disease and possible treatments
and potential complications had been carefully explained. The
study was approved by the local ethics committee.
Preoperative endoscopic retrograde cholangiopancreatography
(ERCP) was performed in patients with serum bilirubin levels of
>10 mg/dl or when biliary obstruction was associated with high
liver enzymes (more than three-fold the normal level (i.e.
>120 IU/ml).4
Randomization
Patients enrolled in the study were randomized into two groups
using the closed envelope method. Envelopes were drawn and
opened by a nurse not otherwise engaged in the study in the
operating room after resection. Patients in one group underwent
IRPJ with isolated pancreatic drainage and patients in the other
underwent PG. No patient was excluded after resection of the
tumour. The same surgeons, who had equivalent levels of exper-
tise, performed PD in both groups.
Operative techniques
Standard PD was performed after the pancreatic head and duo-
denum had been mobilized. The pancreas was divided anteriorly
and to the left of the superior mesenteric vein and portal vein.
Antrectomy was performed in all patients.
Isolated Roux loop PJ group
Pancreaticojejunostomy was constructed in two layers after the
performance of a small jejunostomy in the isolated jejunal loop
equal to the diameter of the pancreatic duct. The duct and the
entire thickness of the pancreatic parenchyma were sutured to the
full thickness of the jejunum using 5/0 vicryl interrupted sutures
in a radial manner and 3/0 silk interrupted sutures to attach the
outer seromuscular layer to the pancreatic capsule without pan-
creatic stenting. A separate Roux loop was created for the end-to-
side hepaticojejunostomy (HJ) and the end-to-side antecolic
gastrojejunostomy (GJ). The PJ loop was anastomosed to the
main loop (Fig. 1).
Pancreaticogastrostomy group
The proximal part of the pancreatic remnant was mobilized from
the splenic vessels and the retroperitoneum for subsequent anas-
tomosis to the posterior gastric wall. The PG was constructed in
two layers. A seromuscular suture was performed between the
posterior wall of the stomach and pancreatic capsule using either
interrupted or continuous 3/0 silk. A 2.5–3.0-cm gastrostomy was
performed and the pancreatic parenchyma with the duct were
sutured to the full thickness of the stomach using interrupted or
continuous 5/0 vicryl sutures. The outer seromuscular layer
between the stomach and pancreatic capsule was sutured using
3/0 silk interrupted sutures without pancreatic stenting.
Biliary drainage was achieved by end-to-side HJ (retrocolic).
Gastric drainage was achieved by an antecolic end-to-side GJ
30 cm caudal to the HJ.
Postoperative management
All patients were admitted to the intensive care unit (ICU) for at
least 1 day before transfer to the ward. Octreotide was given to all
patients routinely for 4 days. Outputs from operatively placed
drains and nasogastric tubes were recorded daily. Patients
resumed oral feeding on a fluid diet followed by a regular diet
once bowel sounds were present and patients were able to tolerate
oral feeding.
Serum and drainage fluid amylase was measured on postopera-
tive days (PoDs) 1 and 5. Abdominal ultrasound was performed
routinely in all patients. Ultrasound-guided percutaneous drain-
age was performed in patients who demonstrated an abdominal
collection.
Follow-up was conducted at 1 week, 3 months and 6 months
postoperatively, and then at 1 year. Patients were also seen at
outpatient clinics if symptoms developed between follow-up
visits.
Assessments
The primary outcome was the rate of POPF. Postoperative pan-
creatic fistula was defined according to the International Study
Group on Pancreatic Fistula (ISGPF) definition as any measurable
volume of fluid on or after PoD 3 with amylase content greater
than three times serum amylase activity.18,19 The severity of POPF
was assessed using the Dindo–Clavien system of classification as
Grade I (no need for specific intervention), Grade II (need for
drug therapy such as antibiotics, blood transfusion, total paren-
teral nutrition), Grades IIIa and IIIb (need for invasive radiologi-
cal, endoscopic or surgical therapy), Grades IVa and IVb (organ
dysfunction requiring an ICU stay and management), and Grade
V (death).20 Complications of severity higher than Clavien–Dindo
714 HPB
HPB 2014, 16, 713–722 © 2014 International Hepato-Pancreato-Biliary Association
Grade III were considered to be major complications. Pancreatic
fistulae were graded according to ISGPF criteria into Grades A, B
and C according to their clinical course.18,19
Secondary outcomes included total operative time, operative
time for reconstruction, length of postoperative stay, postopera-
tive complications (including delayed gastric emptying, biliary
leakage, bleeding PG, bleeding GJ, internal haemorrhage and pul-
monary complications), endocrine and exocrine functions, need
for re-exploration, and survival rate. Biliary leak was defined
according to ISGPF criteria as the presence of bile in drainage
fluid persisting to PoD 4. Delayed gastric emptying was defined as
output from a nasogastric tube of >500 ml per day persisting
beyond PoD 10, failure to maintain oral intake by PoD 14, or need
for the reinsertion of a nasogastric tube.18,19
Complications were graded according to severity on a validated
5-point scale using the Dindo–Clavien complication classification
system into Grades I, II, IIIa and IIIb, IVa and IVb, and V.20
To assess endocrine function, fasting blood glucose level was
measured without the administration of oral hypoglycaemic
drugs or insulin (normal level: <110 mg/dl). Any diagnosis of
diabetes mellitus (DM) was based on criteria established by the
World Health Organization study group on DM.21
Pancreatic exocrine function was evaluated. Patients who were
taking pancreatic enzyme supplements were asked to stop this
treatment at least 10 days before the clinical evaluation. Patients
were asked about the presence of steatorrhea (more than three
stools per day, faecal output of >200 g/day for at least 3 days, pale
or yellow stools, and stools with a pasty or greasy appearance).
Severe steatorrhea was defined by the presence of at least three of
these criteria, need for pancreatic enzyme supplements, and pre-
and postoperative variation in body weight.22
Data collected
Preoperative and intraoperative variables included patient demo-
graphics, liver status, tumour size, pancreatic duct diameter,
texture of the pancreas, operative time, blood loss and blood
transfusion.
Postoperative variables included postoperative complications,
drain output and nature, drain amylase, liver function, days to
resumption of oral feeding, postoperative stay, re-exploration,
hospital mortality, postoperative pathology, fasting blood sugar at
1 year, postoperative weight compared with preoperative weight,
and presence or absence of steatorrhea.
A sample size for each group was calculated to set the level of
power for the study at 80% with a 5% significance level supposing
POPF rates of 17% after PG4–6 and 0% after IRPJ.14–16 Based on
these parameters, a sample size of 45 subjects in each group was
deemed to be sufficient.
Statistical analysis in this study was performed using spss
Version 17 (SPSS, Inc., Chicago, IL, USA). Data were analysed on
an intension-to-treat basis. For continuous variables, descriptive
statistics were calculated and described as medians and ranges.
Categorical variables were reported using percentages of the total
number of patients (n = 90) and of the number of patients in each
group (n = 45). Student’s t-test was used to detect differences in
the means of continuous variables. The chi-squared test was used
Figure 1 Graphic representation of isolated Roux loop pancreaticojejunostomy (PJ) carried out using a 40-cm isolated loop of jejunum for
PJ, and a Roux loop for hepaticojejunostomy (HJ) and gastrojejunostomy (GJ) (50 cm caudal to the HJ). The PJ loop was anastomosed to
the main loop (20 cm caudal to the GJ)
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for categorical variables. P-values of <0.05 were considered to
indicate statistical significance. Significance was two-tailed.
Results
Patient characteristics
The study flow chart is shown in Fig. 2. The characteristics of the
two randomized groups are presented in Table 1. Intraoperative
data are shown in Table 2. Postoperative data are shown in Table 3.
Ultrasound-guided tubal drainage to resolve an intra-
abdominal collection was required in four patients in the IRPJ
group and six patients in the PG group (P = 0.502).
Longterm outcomes are shown in Table 4.
Discussion
The safe reconstruction of the pancreatic anatomy after PD
continues to challenge pancreatic surgeons.1–3 Ideally, the
Assessed for eligibility (n = 98)
Enrolment
Excluded (n = 8)
Not meeting inclusion criteria (n = 6)
Patients with advanced liver cirrhosis (2)
Patients underwent hepaticojejunostomy (3)
Patients with coagulopathy (1)
Refused to participate (n = 2)
Randomized (n = 90)
Allocation
Follow-up
Analysis
Allocated to PD with isolated Roux loop PJ
(n = 45)
Received allocated intervention (n = 45)
Allocated to PD with PG (n = 45)
Received allocated intervention (n = 45)
Lost to follow-up (n = 0) Lost to follow-up (n = 0)
Analysed (n = 45) Analysed (n = 45)
Figure 2 Flow diagram showing progress through the phases of this randomized trial (i.e. enrolment, intervention allocation, follow-up and
data analysis). PD, pancreaticoduodenectomy; PG, pancreaticogastrostomy; PJ, pancreaticojejunostomy
Table 1 Demographic data for patients submitted to isolated Roux loop pancreaticojejunostomy (IRPJ) or pancreaticogastrostomy (PG)
Variable All patients IRPJ group PG group P-value
(n = 90) (n = 45) (n = 45)
Patient age, years, median (range) 55.5 (12–73) 54 (15–73) 58 (12–73) 0.105
Sex, n (%)
Female 40 (44.4%) 18 22 0.396
Male 50 (55.6%) 27 23
Symptoms, n (%)
Jaundice 83 (92.2%) 41 42 0.694
Abdominal pain 69 (76.7%) 34 35 0.803
Loss of weight 19 (21.1%) 12 7 0.197
Body mass index, kg/m2, median (range) 21 (17–34) 21 (17–34) 22 (17–32) 0.321
Preoperative bilirubin, mg/dl, median (range) 3.2 (0.4–36.0) 4.4 (0.5–25.7) 2.7 (0.4–36.0) 0.325
Preoperative biliary drainage (ERCP), n (%) 54 (60.0%) 23 31 0.089
ERCP, endoscopic retrograde cholangiopancreatography.
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reconstructive technique should not only minimize the risk for
POPF, but should decrease its severity if POPF does occur and
should also maintain exocrine and endocrine pancreatic func-
tions. Pancreaticogastrostomy has several potential advantages
over PJ. The PG anastomosis is technically feasible and easy to
perform, and contributes towards a lower tendency for ischaemia
and less tension as a result of anatomical factors. The gastric acid
environment is thought to inhibit the activation of pancreatic
enzymes and prevent the breakdown effect of proteolytic enzymes
on the anastomosis.2,23–25
Incidences of POPF after PD using PG reconstruction range
from 3% to 14.3%.4,6–10 Several studies have reported low rates of
POPF after PD using IRPJ reconstruction in the range of 0–10.9%,
and related decreases in morbidity and mortality15,16,26–32 (Table 5).
Hence, the aim of this study was to compare the outcomes of IRPJ
with those of PG after PD.
Isolated Roux loop PJ was first reported in 1976 by Machado
et al.30 In many studies, IRPJ did not avoid POPF but did decrease
leak-related morbidity and mortality.14–17 In a prospective
randomized study of 216 patients, Ke et al.17 found similar rates of
POPF in patients undergoing conventional loop PJ and IRPJ, but
the ratio of Grade B POPF was much higher in the conventional PJ
group than the IRPJ group. Other studies have reported lower leak
rates and no leak-related mortality after IRPJ.16,28,29,32–38 In the
current study, the isolated Roux loop did not decrease the inci-
dence or severity of POPF.
These findings conform with those of a recently published
survey conducted in Japanese centres, which revealed no
difference between conventional PJ and PG in rates of
POPF, bleeding, abdominal collection and mortality after pan-
creatic head resection in 3109 patients.39,40 All prospective
randomized studies have failed to show significant differ-
ences, which suggests that PJ and PG provide equally good
results.2,23,41,42
Sutton et al. have previously reported the obstruction of the
distal enteroenterostomy secondary to oedema leading to luminal
pressure-induced POPF as a theoretical danger of IRPJ recon-
struction.16 This problem was not observed in the current study,
Table 2 Operative data for patients submitted to isolated Roux loop pancreaticojejunostomy (IRPJ) or pancreaticogastrostomy (PG)
Variable All patients IRPJ group PG group P-value
(n = 90) (n = 45) (n = 45)
Cirrhotic liver, n (%) 12 (13.3%) 7 5 0.535
Size of mass, cm, median (range) 2 (0.5–6.0) 2 (0.5–6.0 cm) 3 (1.0–4.0) 0.477
<2 cm, n (%) 46 (51.5%) 26 20 0.206
>2 cm, n (%) 44 (48.5%) 19 25
Ampullary site, n (%) 36 (40.0%) 19 17
Pancreatic head mass 46 (51.1%) 20 26 0.313
Duodenal tumour 6 (6.7%) 4 2
Lower CBD tumour 2 (2.2%) 2 0
Indication for resection, n (%)
Malignant 75 (83.4%) 38 37 0.466
Benign 13 (14.4%) 6 7
Borderline 2 (2.2%) 1 1
Pancreatic duct diameter, mm, median (range) 3.5 (1–12) 3 (1–12) 4 (2–10) 0.632
<3 mm, n (%) 43 (47.8%) 21 22 0.833
>3 mm, n (%) 47 (52.2%) 24 23
Pancreatic duct to posterior border, mm, median (range) 3 (1–15) 3 (1–15) 3 (1–15) 0.537
<3 mm, n (%) 46 (51.1%) 23 23 1
>3 mm, n (%) 44 (48.9%) 22 22
Pancreatic consistency, n (%)
Firm 42 (46.7%) 23 19 0.398
Soft 48 (53.3%) 22 26
Pancreatic remnant mobilization, cm, median (range) 2 (1–3) 2 (1–2) 2 (1–3) 0.039
Total operative time, min, median (range) 300 (210–480) 320 (240–480) 300 (210–420) 0.047
Operative time for reconstruction, min, median (range) 110 (90–125) 115 (95–125) 100 (90–120) <0.001
Blood loss, ml, median (range) 500 (50–3000) 500 (50–2500) 400 (100–3000) 0.732
CBD, common bile duct.
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possibly because a wide enteroenterostomy was performed in all
patients.
A possible disadvantage of IRPJ is that it requires an additional
enteroenterostomy, which increases operative time.14,17 Median
total and reconstructive operative times in the current study were
longer in the IRPJ group.
In the current study, oral feeding commenced 1 day earlier in
the IRPJ group than in the PG group. Patients with POPF after
IRPJ resumed oral feeding without any increase in the amount of
leak and demonstrated a principal advantage in the absence of
delayed gastric emptying. However, some studies have found no
significant difference in either of these factors.14–17
In the current study, the frequency of severe steatorrhea at 1
year post-surgery was significantly higher in the PG than in the
IRPJ group (P = 0.029). Correspondingly, median albumin at 1
year was significantly higher in the IRPJ group than in the PG
Table 3 Postoperative data for patients submitted to isolated Roux loop pancreaticojejunostomy (IRPJ) or pancreaticogastrostomy (PG)
Variable All patients IRPJ group PG group P-value
(n = 90) (n = 45) (n = 45)
Hospital stay, days, median (range) 8 (4–41) 8 (5–41) 9 (4–34) 0.448
Time to drain removal, days, median (range) 8 (4–35) 7.5 (5–35) 9 (4–34) 0.118
Amount of draining, ml, median (range) 900 (65–17000) 850 (70–15000) 950 (65–17000) 0.705
Time to oral feeding, days, median (range) 6 (4–30) 5 (4–20) 6 (4–30) 0.029
Patients with complications, n (%) 31 (34.4%) 14 17 0.506
Complication grade, n (%)
I 3 (3.3%) 2 1 0.724
II 10 (11.1%) 5 5
IIIa 5 (5.6%) 2 3
IIIb 6 (6.7%) 2 4
IV 7 (7.8%) 3 4
V 7 (7.8%) 3 4
Severity of complications, n (%)
Minor (<IIIb) 14 (15.5%) 8 6 0.385
Major (>IIIb) 17 (18.9%) 6 11
Pancreatic leakage (POPF), n (%) 19 (21.1%) 9 10 0.796
POPF Grade A, n (%) 8 (8.9%) 5 3 0.710
POPF Grade B, n (%) 5 (5.6%) 2 3
POPF Grade C, n (%) 6 (6.7%) 2 4
Pancreatitis, n (%) 3 (3.3%) 2 1 0.557
Biliary leakage, n (%) 10 (11.1%) 4 6 0.502
Delayed gastric emptying, n (%) 13 (14.4%) 4 9 0.134
Obstructed GJ, n (%) 2 (2.2%) 1 1 1
Bleeding GJ, n (%) 2 (2.2%) 1 1 1
Bleeding PG, n (%) 2 (2.2%) 0 2 0.153
Internal haemorrhage, n (%) 2 (2.2%) 1 1 1
Wound infection, n (%) 5 (5.6%) 3 2 0.645
Liver failure, n (%) 1 (1.1%) 1 0
Pulmonary complications, n (%) 4 (4.4%) 2 2 1
Re-exploration, n (%) 7 (7.8%) 3 4 0.694
Readmission rate at 3 months, n (%) 6 (6.7%) 2 4 0.398
Mortality, n (%) 7 (7.8%) 3 4 0.694
Pulmonary embolism, n (%) 1 (1.1%) 1 0
SIRS secondary to POPF, n (%) 5 (5.6%) 2 3
Liver failure, n (%) 1 (1.1%) 0 1
POPF, postoperative pancreatic fistula; GJ, gastrojejunostomy; PG, pancreaticogastrostomy; SIRS, systemic inflammatory response syndrome.
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group (3.6 g/dl versus 3.3 g/dl; P ≤ 0.001). Several published series
have reported that exocrine function after PD depends on various
complex factors, including pre-existing obstructive pancreatitis by
tumour, the degree of fibrosis in the pancreatic remnant, the
volume of resected pancreatic parenchyma, impairment of pan-
creatic juice flow as a result of anastomotic stricture or swelling
of the gastric mucosa, and possibly the type of pancreatic
reconstruction.13,43–46 Some retrospective studies have reported
higher rates of suggested pancreatic exocrine insufficiency in
patients with longterm follow-up who have undergone PG rather
than PJ reconstruction.11–13,29 There is, however, no evidence
that impaired pancreatic endocrine function would be associated
more often with a certain type of reconstruction.43
Pancreaticogastrostomy may cause more morphological and
functional derangement because the reflux of gastric juice causes
the inactivation of pancreatic enzymes and early pancreatic
insufficiency.11,12,22
The present study is subject to two limitations. Firstly, the
sample size was calculated to set the level of power for the study at
80% with a 5% significance level, presupposing POPF rates of
17% after PG4–6 and 0% after IRPJ.14–16 The calculation of the
sample size in relation to the 4–14% incidence of POPF after
IRPJ15,17,36 yielded large numbers in excess of 100 patients per
group, which exceeded the proposed duration of the trial. Sec-
ondly, the operations were performed by eight surgeons, which
may have represented a source of bias. However, the fact that these
surgeons had almost equal levels of experience within the trial
helps to overcome this. Nonetheless, further prospective
randomized studies with larger sample sizes are required to
confirm these results.
Conclusions
The results of this study contribute to evidence indicating that
IRPJ is not associated with a lower rate of POPF, but is associ-
ated with a decrease in the incidence of postoperative
steatorrhea. Isolated Roux loop PJ allowed for early oral feeding
and facilitated the maintenance of oral feeding even if POPF
developed.
Conflicts of interest
None declared.
Table 4 Functional changes in patients submitted to isolated Roux loop pancreaticojejunostomy (IRPJ) or pancreaticogastrostomy (PG)
Variable IRPJ group PG group P-value
(n = 45) (n = 45)
Preoperative steatorrhea, n 8/45 10/45 0.598
Postoperative steatorrhea, n 9/42 18/41 0.029
P-value 0.157 0.005
Need for pancreatic enzyme supplements, n 9/42 18/41 0.029
Preoperative albumin, g/dl, median (range) 4 (3.2–5) 4 (3.3–4.8) 0.915
Postoperative albumin, g/dl, median (range) 3.6 (3.1–4.5) 3.3 (2.5–4.1) <0.001
P-value <0.001 <0.001
Preoperative weight, kg, median (range) 71 (54–121) 72 (54–72) 0.596
Postoperative weight, kg, median (range) 71 (52–99) 70 (50–105) 0.789
P-value <0.001 <0.001
Preoperative body mass index, n
<25 kg/m2 30/45 26/45 0.384
>25 kg/m2 15/45 19/45
Postoperative body mass index, n
<25 kg/m2 34/42 34/41 0.815
>25 kg/m2 8/42 7/41
P-value 0.025 0.002
Preoperative diabetes mellitus, n 11/45 13/45 0.634
Postoperative diabetes mellitus, n 12/42 20/41 0.059
P-value 0.157 0.008
Preoperative fasting blood sugar, mg/dl, median (range) 114 (71–275) 102 (79–217) 0.477
Postoperative fasting blood sugar, mg/dl, median (range) 102 (70–210) 132 (90–299) 0.022
P-value 0.004 <0.001
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